Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world’s toughest challenges in the defense, intelligence, homeland security, civil, and health markets. Explorations in Global Health (ExGloH) is a division of Leidos Health. Focusing on discovery and early pre-clinical pathways, ExGloH quickly identifies potential therapeutics that complement the technical gaps in biotech and pharma. ExGloH’s mission is to meet the unmet needs related to immune-therapy. First, a drug that works like current marketed products but avoids side effects that make combination therapies less feasible. Second, a low-side option for infectious diseases therapeutic or vaccine adjuvant. Our research centers on discovery, formulation feasibility, mechanism of action, and proof of concept in an appropriate model of disease. Our scientists have decades of experience in advancing infectious disease vaccines through phase 1 clinical trials.